7 ms·
First of its kind study pits psilocybin against a common antidepressant
- spiritplumber 6y agoWasn't this tested 50 years ago and then sort of left dormant?
- arpa 6y agoPsychedelic psychotherapy was left as a casualty to the war on drugs.
- ridaj 6y ago? The war on drugs didn't prevent a massive rise in opioid medication
- humantorso 6y agoAre opioids psychoactive?
- AstralStorm 6y agoYes, but not hallucinogenic or psychedelic. (Whichever word you prefer.)
- jMyles 6y ago> Are opioids psychoactive? Yes, obviously. But the idea that psychoactivity is a (or the?) determining characteristic of a compound in determining whether it is prohibited is silly on its face.
- cjaybo 6y agoWhat does that have to do with psychedelic psychotherapy?
- n4r9 6y agoOpioid medication isn't psychedelic psychotherapy, nor has it ever had strong associations with anti-establishment movements.
- nicklecompte 6y agoThe major difference is that opioids had been used for pain treatment in modern medicine decades before the war on drugs, so legal prohibitions on recreational opioids didn’t affect basic research nor the development of new treatments, nor did it affect the legitimacy of opioid treatments in the eyes of the US medical establishment. (perhaps it should have!) By contrast, psychedelics have not been used in medicine and were/are not considered “legitimate” by the medical establishment. So with legal prohibitions on actually obtaining and administering psychedelics, the War on Drugs actually did hinder psychedelics medical research.
- scrollbar 6y agoYou’re correct and parent is correct. War on Drugs started as a combined anti-black anti-counterculture initiative in response to Vietnam War. Psychedelics were threatening the power structure. It was never really about drugs.
- neom 6y agoThere is also an argument to be made that Timothy Leary made a real mess of things and at minimum, certainly didn't help the situation any.
- spiritplumber 6y agoI've helped scan and archive Timothy Leary's stuff (I was dating his testamentary executor for a while). He certainly had an interesting life! I don't see how he made a mess of things.
- neom 6y agoFirst and foremost, thank you for your work! And I would certainly say you're likely considerably more versed than I. From my research, I felt like his escapades at Millbrook and also his shenanigans with harvard did 2 things: On Millbrook, pushed away from his work as serious work and more towards play, that rubbed people the wrong way. On Harvard, I don't think the universities were as open to ideas in that direction after he caused a ruckus. I did quite a bit of research, but it was years ago, if you wanna drop me an email I'll see if I can rustle up the things that lead me down that thought path and send them over, it was mostly from interviews of others around that time.
- rincebrain 6y agoRelated prior discussion: https://news.ycombinator.com/item?id=26816444 https://news.ycombinator.com/item?id=26816444
- yosito 6y ago> While members of the psychedelic cohort received 25 milligrams of psilocybin during the sessions, considered a medium-to-heavy dose of the drug, those in the antidepressant group received 1 milligram. Such a low dose is typically provided in psychedelic studies in lieu of a placebo Doesn't seem like well-designed study.
- galangalalgol 6y agoCan you explain why for those of us unfamiliar?
- realce 6y agoWell it's not actually a placebo to start with.
- AstralStorm 6y agoThere is no way to placebo control a psychedelic really, as that effect is easily discerned, even in a closed label trial. Therefore, a comparison protocol is used instead, which is anyway superior to pure placebo control. A different psychedelic, which is not expected to have an antidepressant effect, or a low, psychoactive but not antidepressant dose. Or known non-psychedelic antidepressants which have been placebo tested.
- ghgdynb1 6y agoI think the concern is that you could still be getting pharmacodynamic effects at 1mg, so the control wouldn’t really be a control. It’s entirely feasible that you could get good results and limited side effects at dose x, and poor results overwhelmed by side effects at dose 25x.
- nicklecompte 6y agoI agree that this is a bad flaw but the reasoning about the “nocebo” effect does make sense: administering a placebo actually confounds the results if the participants know it’s a placebo, and it will be pretty obvious it the pill you took doesn’t have any psychedelics. Studies like these are inherently difficult, this isn’t an issue of poor design.
- bransonf 6y ago> “In hindsight I wish we’d made these other measures of well-being the primary outcome measure,” he said. “However the world — the Food and Drug Administration, the European Medicines Agency — doesn’t recognize those measures as valid.” Am I understanding this correctly? Other academics are critical of the outcome measured, but it was specifically chosen because of recognition by national authorities.
- datameta 6y agoIf I understood it correctly I took it to mean that the organizers of the study would have preferred to lean primarily on what government health agencies see as secondary or invalid measures of well-being.
- rank0 6y ago25 is a pretty fat dose. Seems excessive for a scientific study... I always wonder how these people running the studies choose their doses. Do we want the participants to have a smooth/pleasant trip? Or have an white knuckle, ego-obliterating flight through space? This reminds me of another study I read where participants were given 100+mg doses of liquid ketamine straight to the dome. The participants frequently k-holed. Maybe the science says otherwise, but personal experience tells me you don't need to melt your fucking face to experience the anti-depressant effects of psychedelics. It can be destabilizing to some.
- api 6y agoIt would be really interesting to study the dose response curve in regard to a single thing like depression. Do microdoses or mild doses help more or less than a Zoom call with God dose? For a medical use I'd be concerned about the unpredictability of the experience with high doses. A traumatic or chaotic trip could make depression worse or possibly trigger other latent psychological issues.
- Red_Leaves_Flyy 6y agoI imagine it would get really expensive real fast to test the whole range of, what, at least a few dozen substances? Are there any efforts to make running experiments cheaper and faster?
- deleted 6y ago[deleted]
- Tenoke 6y ago25 is as they say 'medium-to-heavy dose'. It's not as excessively high as you make it sound and it isn't quite 'an white knuckle, ego-obliterating flight through space' It's definitely a 'proper trip' but you are making it seem like a DMT breakthrough amount.
- mtalantikite 6y agoYeah, agreed. I know mushrooms are highly variable in their psilocybin and psilocin content, but it’s generally around 1% of dried mass for cubensis from what I’ve read. So in this case that’s what, 2.5 grams of mushrooms about? That’s not nothing, but it certainly isn’t an ego death sort of dose. I know a lot of people that will take 3.5 grams for a typical “journey” when they’re seeking to get in there and do some internal work. It seems like a perfectly fine dose for a study like this: not too overwhelming and not too small.